Drug information for SODIUM THIOSULFATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
250MG/ML
Discontinued
SODIUM THIOSULFATE
sodium thiosulfate
US ARMY
20166
SOLUTION; INTRAVENOUS
12.5GM/50ML (250MG/ML)
Prescription
(Reference Drug)
SODIUM THIOSULFATE
sodium thiosulfate
HOPE PHARMS
203923
2012-03-15 Review
2012-03-15 Summary Review
2012-02-21 Letter
2012-02-17 Label
Drug Adverse Effects information for SODIUM THIOSULFATE
Role code
Indications
Reaction
# Reports
SS
CALCIPHYLAXIS
FLUID OVERLOAD
1
SS
CALCIPHYLAXIS
FURUNCLE
1
SS
CALCIPHYLAXIS
GAIT DISTURBANCE
1
SS
CALCIPHYLAXIS
HYPOTENSION
1
SS
CALCIPHYLAXIS
MOBILITY DECREASED
1
SS
CALCIPHYLAXIS
OEDEMA PERIPHERAL
1
SS
OESOPHAGEAL SQUAMOUS CELL CARCINOMA
LEUKOPENIA
1
SS
OESOPHAGEAL SQUAMOUS CELL CARCINOMA
STOMATITIS
1
SS
PERITONEAL DIALYSIS
FLUID OVERLOAD
1
SS
PERITONEAL DIALYSIS
FURUNCLE
1
SS
PERITONEAL DIALYSIS
GAIT DISTURBANCE
1
SS
PERITONEAL DIALYSIS
HYPOTENSION
1
SS
PERITONEAL DIALYSIS
MOBILITY DECREASED
1
SS
PERITONEAL DIALYSIS
OEDEMA PERIPHERAL
1
SS
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED
HAEMOGLOBIN DECREASED
2
SS
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED
LEUKOPENIA
3
SS
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED
MOUTH HAEMORRHAGE
2
SS
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED
STOMATITIS
3
SS
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED
VASCULAR PSEUDOANEURYSM
2
C
ANGIOGRAM
ARTHRALGIA
5
C
ANGIOGRAM
DYSSTASIA
5
C
ANGIOGRAM
GAIT DISTURBANCE
5
C
ANGIOGRAM
JOINT CONTRACTURE
5
C
ANGIOGRAM
JOINT RANGE OF MOTION DECREASED
5
C
ANGIOGRAM
LICHENIFICATION
5
C
ANGIOGRAM
NEPHROGENIC SYSTEMIC FIBROSIS
5
C
ANGIOGRAM
OCULAR ICTERUS
5
C
ANGIOGRAM
OEDEMA PERIPHERAL
5
C
ANGIOGRAM
PAIN
5
C
ANGIOGRAM
PULMONARY FIBROSIS
5
C
ANGIOGRAM
SKIN HYPERPIGMENTATION
5
C
ANGIOGRAM
SKIN INDURATION
5
C
ANGIOGRAM
SKIN TIGHTNESS
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
ARTHRALGIA
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
DYSSTASIA
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
GAIT DISTURBANCE
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
JOINT CONTRACTURE
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
JOINT RANGE OF MOTION DECREASED
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
LICHENIFICATION
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
NEPHROGENIC SYSTEMIC FIBROSIS
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
OCULAR ICTERUS
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
OEDEMA PERIPHERAL
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PAIN
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PULMONARY FIBROSIS
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN HYPERPIGMENTATION
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN INDURATION
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN TIGHTNESS
5
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
ARTHRALGIA
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
DYSSTASIA
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
GAIT DISTURBANCE
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
JOINT CONTRACTURE
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
JOINT RANGE OF MOTION DECREASED
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
LICHENIFICATION
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
NEPHROGENIC SYSTEMIC FIBROSIS
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
OCULAR ICTERUS
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
OEDEMA PERIPHERAL
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
PAIN
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
PULMONARY FIBROSIS
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
SKIN HYPERPIGMENTATION
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
SKIN INDURATION
1
C
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN
SKIN TIGHTNESS
1
Ads by Google